A path forward in the debate over health impacts of endocrine disrupting chemicals

Environmental Health: A Global Access Science Source

Volumn 13, Issue 1, 2014, Pages

  Thomas Zoeller, R ^a   Bergman, Ake ^b   Becher, Georg ^c   Bjerregaard, Poul ^d   Bornman, Riana ^e   Brandt, Ingvar ^f   Iguchi, Taisen ^g   Jobling, Susan ^h   Kidd, Karen A ⁱ   Kortenkamp, Andreas ^h   Skakkebaek, Niels E ^j   Toppari, Jorma ^k   Vandenberg, Laura N ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b Swedish Toxicology Sciences Research Center   (Sweden)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^e UNIVERSITY OF PRETORIA   (South Africa)

^f UPPSALA UNIVERSITY   (Sweden)

^g NATIONAL INSTITUTE FOR BASIC BIOLOGY   (Japan)

^h BRUNEL UNIVERSITY   (United Kingdom)

ⁱ UNIVERSITY OF NEW BRUNSWICK   (Canada)

^j UNIVERSITY OF COPENHAGEN   (Denmark)

^k UNIVERSITY OF TURKU   (Finland)

more..

Author keywords

Endocrine disruptor; State of the science; UNEP; WHO

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 4,4' ISOPROPYLIDENEDIPHENOL; ANDROGEN; BENZYL PARABEN; DIETHYLSTILBESTROL; ENDOCRINE DISRUPTOR; ESTRADIOL; ETHINYLESTRADIOL; HORMONE; INSULIN; POLYCHLORINATED BIPHENYL; THYROID HORMONE;

ENDOCRINE DISRUPTOR; HEALTH IMPACT; HORMONE; LITERATURE REVIEW; RISK ASSESSMENT; SCIENCE AND TECHNOLOGY; UNITED NATIONS ENVIRONMENT PROGRAM; WORLD HEALTH ORGANIZATION;

ADVERSE DRUG REACTION; ENDOCRINE SYSTEM; ENDOCRINOLOGY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GOOD LABORATORY PRACTICE; HEALTH HAZARD; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; LD50; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 85017330115     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/1476-069X-13-118     Document Type: Review

References (58)

1. Kortenkamp A, Martin O, Faust M, Evans R, McKinlay R, Orton F, Rosivatz E: State of the Art Assessment of Endocrine Disruptors Final Report. Brussels: European Commission; 2011:442.
2. Rhomberg LR, Goodman JE, Foster WG, Borgert CJ, Van Der Kraak G: A critique of the European Commission document, "State of the Art Assessment of Endocrine Disrupters". Crit Rev Toxicol 2012, 42:465-473.
3. Kortenkamp A, Martin O, Evans R, Orton F, McKinlay R, Rosivatz E, Faust M: Response to a critique of the European Commission Document, "State of the Art Assessment of Endocrine Disrupters" by Rhomberg and colleagues-letter to the editor. Crit Rev Toxicol 2012, 42:787-789. author reply 790-781.
4. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR Jr, Lee DH, Shioda T, Soto AM, vom Saal FS, Welshons WV, Zoeller RT, Myers JP: Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocrinol Rev 2012, 33:378-455.
5. Rhomberg LR, Goodman JE: Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: has the case been made? Regul Toxicol Pharmacol 2012, 64:130-133.
6. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR, Lee DH, Myers JP, Shioda T, Soto AM, Vom Saal FS, Welshons WV, Zoeller RT: Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology. Reprod Toxicol 2013, 38C:1-15.
7. Horel S, Bienkowski B: Special report: scientists critical of EU chemical policy have industry ties. In Environmental Health News. Environmental Health Sciences; 2013.
8. Dietrich D, von Aulock S, Marquardt HW, Blaauboer BJ, Dekant W, Kehrer J, Hengstler JG, Collier AC, Gori GB, Pelkonen O, Lang F, Nijkamp FP, Stemmer K, Li A, Savolainen K, Hayes AW, Gooderham N, Harvey A: Open letter to the European Commission: scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science, and risk assessment principles. Arch Toxicol 2013, 87:1739-1741.
9. Gore AC, Balthazart J, Bikle D, Carpenter DO, Crews D, Czernichow P, Diamanti-Kandarakis E, Dores RM, Grattan D, Hof PR, Hollenberg AN, Lange C, Lee AV, Levine JE, Millar RP, Nelson RJ, Porta M, Poth M, Power DM, Prins GS, Ridgway EC, Rissman EF, Romijn JA, Sawchenko PE, Sly PD, Söder O, Taylor HS, Tena-Sempere M, Vaudry H, Wallen K, et al: Policy decisions on endocrine disruptors should be based on science across disciplines: A response to Dietrich et al. Endocrinology 2013, 154:3957-3960.
10. Bergman A, Andersson AM, Becher G, van den Berg M, Blumberg B, Bjerregaard P, Bornehag CG, Bornman R, Brandt I, Brian JV, Casey SC, Fowler PA, Frouin H, Giudice LC, Iguchi T, Hass U, Jobling S, Juul A, Kidd KA, Kortenkamp A, Lind M, Martin OV, Muir D, Ochieng R, Olea N, Norrgren L, Ropstad E, Ross PS, Rudén C, Scheringer M, et al: Science and policy on endocrine disrupters must not be mixed: A reply to a "common sense" intervention by toxicology journal editors. Environ Health 2013, 12:69.
11. Bergman A, Heindel JJ, Jobling S, Kidd KA, Zoeller RT: State of the Science of Endocrine Disrupting Chemicals 2012. Geneva, Switzerland: World Health Organization; 2013.
12. Lamb JC, Boffetta P, Foster WG, Goodman JE, Hentz KL, Rhomberg LR, Staveley J, Swaen G, Kraak GV, Williams AL: Critical comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals-2012. Regul Toxicol Pharmacol 2014, 69:22-40.
13. Minutes of the Expert Meeting on Endocrine Disruptors. [http://ec.europa. eu/commission-2010-2014/president/chief-scientific-Adviser/documents/minutes-endocrine-disruptors-meeting-241013-final.pdf]
14. Nohynek GJ, Borgert CJ, Dietrich D, Rozman KK: Endocrine disruption: fact or urban legend? Toxicol Lett 2013, 223:295-305.
15. Zoeller RT, Brown TR, Doan LL, Gore AC, Skakkebaek NE, Soto AM, Woodruff TJ, Vom Saal FS: Endocrine-disrupting chemicals and public health protection: A statement of principles from the endocrine society. Endocrinology 2012, 153:4097-4110.
16. Damstra T, Barlow S, Bergman A, Kavlock RJ, van der Kraak G (Eds): Global Assessment of the State-of-The-Science of Endocrine Disruptors. Geneva, Switzerland: World Health Organization; 2002.
17. Kavlock RJ, Daston GP, DeRosa C, Fenner-Crisp P, Gray LE, Kaattari S, Lucier G, Luster M, Mac MJ, Maczka C, Miller R, Moore J, Rolland R, Scott G, Sheehan DM, Sinks T, Tilson HA: Research needs for the risk assessment of health and environmental effect of endocrine disruptors: A report of the US EPA-sponsored workshop. Environ Health Perspect 1996, 104:715-740.
18. European Commission: European workshop on the impact of endocrine disruptors on human health and wildlife. In Environment and Climate Research Programme. Brussels, Belgium: European Commission; 1996.
19. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, Zoeller RT, Gore AC: Endocrine-disrupting chemicals: An Endocrine Society scientific statement. Endocr Rev 2009, 30:293-342.
20. Nadal A, Alonso-Magdalena P, Soriano S, Quesada I, Ropero AB: The pancreatic beta-cell as a target of estrogens and xenoestrogens: implications for blood glucose homeostasis and diabetes. Mol Cell Endocrinol 2009, 304:63-68.
21. Bansal R, Tighe DP, Danai A, Rawn DFK, Gaertner DW, Arnold LA, Gilbert ME, Zoeller RT: Polybrominated diphenyl ether (DE-71) interferes with thyroid hormone action independent of effects on circulating levels of thyroid hormone. Endocrinology 2014, in press.
22. Shioda T, Rosenthal NF, Coser KR, Suto M, Phatak M, Medvedovic M, Carey VJ, Isselbacher KJ: Expressomal approach for comprehensive analysis and visualization of ligand sensitivities of xenoestrogen responsive genes. Proc Natl Acad Sci U S A 2013, 110:16508-16513.
23. DeGroot LJ, Jameson JL: Endocrinology: Adult and Pediatric. 6th edition. Philadelphia: Saunders/Elsevier; 2010.
24. Zoeller RT, Rovet J: Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings. J Neuroendocrinol 2004, 16:809-818.
25. Majdic G, Tobet S: Cooperation of sex chromosomal genes and endocrine influences for hypothalamic sexual differentiation. Front Neuroendocrinol 2011, 32:137-145.
26. Zucchi FC, Yao Y, Metz GA: The secret language of destiny: stress imprinting and transgenerational origins of disease. Front Genet 2012, 3:96.
27. Dyer JS, Rosenfeld CR: Metabolic imprinting by prenatal, perinatal, and postnatal overnutrition: A review. Semin Reprod Med 2011, 29:266-276.
28. IPoCS: IPCS Risk Assessment Terminology. Geneva: World Health Organization; 2004.
29. Arimone Y, Begaud B, Miremont-Salame G, Fourrier-Reglat A, Moore N, Molimard M, Haramburu F: Agreement of expert judgment in causality assessment of adverse drug reactions. Eur J Clin Pharmacol 2005, 61:169-173.
30. Integrated Risk Information Systems (IRIS) Glossary. [http://www.epa.gov/iris/help-gloss.htm]
31. Borgert CJ, Baker SP, Matthews JC: Potency matters: Thresholds govern endocrine activity. Regul Toxicol Pharmacol 2013, 67:83-88.
32. Borgert CJ, Sargent EV, Casella G, Dietrich DR, McCarty LS, Golden RJ: The human relevant potency threshold: reducing uncertainty by human calibration of cumulative risk assessments. Regul Toxicol Pharmacol 2012, 62:313-328.
33. Slob W: Thresholds in toxicology and risk assessment. Int J Toxicol 1999, 18:259-268.
34. White RH, Cote I, Zeise L, Fox M, Dominici F, Burke TA, White PD, Hattis DB, Samet JM: State-of-The-science workshop report: issues and approaches in low-dose-response extrapolation for environmental health risk assessment. Environ Health Perspect 2009, 117:283-287.
35. Tyl RW: In honor of the Teratology Society's 50th anniversary: The role of Teratology Society members in the development and evolution of in vivo developmental toxicity test guidelines. Birth Defects Res (Part C) 2010, 90:99-102.
36. Kanno J, Onyon L, Peddada S, Ashby J, Jacob E, Owens W: The OECD program to validate the rat uterotrophic bioassay. Phase 2: dose-response studies. Environ Health Perspect 2003, 111:1530-1549.
37. Conrad JW, Becker RA: Enhancing credibility of chemical safety studies: emerging consensus on key assessment criteria. Environ Health Perspect 2011, 119:757-764.
38. Birnbaum LS, Bucher JR, Collman GW, Zeldin DC, Johnson AF, Schug TT, Heindel JJ: Consortium-based science: The NIEHS's multipronged, collaborative approach to assessing the health effects of bisphenol A. Environ Health Perspect 2012, 120:1640-1644.
39. Schug TT, Heindel JJ, Camacho L, Delclos KB, Howard P, Johnson AF, Aungst J, Keefe D, Newbold R, Walker NJ, Thomas Zoeller R, Bucher JR: A new approach to synergize academic and guideline-compliant research: The CLARITY-BPA research program. Reprod Toxicol 2013, 40:35-40.
40. Silbergeld EK, Flaws JA, Brown KM: Organizational and activational effects of estrogenic endocrine disrupting chemicals. Cad Saude Publica 2002, 18:495-504.
41. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ: Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004, 291:228-238.
42. Corbetta S, Muzza M, Avagliano L, Bulfamante G, Gaetti L, Eller-Vainicher C, Beck-Peccoz P, Spada A: Gonadal structures in a fetus with complete androgen insensitivity syndrome and persistent Mullerian derivatives: comparison with normal fetal development. Fertil Steril 2011, 95:1119 e1119-1114.
43. Newbold RR: Lessons learned from perinatal exposure to diethylstilbestrol. Toxicol Appl Pharmacol 2004, 199:142-150.
44. Skakkebaek NE, Rajpert-De Meyts E, Jorgensen N, Main KM, Leffers H, Andersson AM, Juul A, Jensen TK, Toppari J: Testicular cancer trends as 'whistle blowers' of testicular developmental problems in populations. Int J Androl 2007, 30:198-204. discussion 204-195.
45. Barouki R, Gluckman PD, Grandjean P, Hanson M, Heindel JJ: Developmental origins of non-communicable disease: implications for research and public health. Environ Health 2012, 11:42.
46. Welshons WV, Thayer KA, Judy BM, Taylor JA, Curran EM, vom Saal FS: Large effects from small exposures: I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ Health Perspect 2003, 111:994-1006.
47. Vandenberg LN: Low-dose effects of hormones and endocrine disruptors. Vitamins and hormones 2014, 94:129-65.
48. Beausoleil C, Ormsby JN, Gies A, Hass U, Heindel JJ, Holmer ML, Nielsen PJ, Munn S, Schoenfelder G: Low dose effects and non-monotonic dose responses for endocrine active chemicals: science to practice workshop: workshop summary. Chemosphere 2013, 93:847-856.
49. Melnick R, Lucier G, Wolfe M, Hall R, Stancel G, Prins G, Gallo M, Reuhl K, Ho SM, Brown T, Moore J, Leakey J, Haseman J, Kohn M: Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review. Environ Health Perspect 2002, 110:427-431.
50. Houlihan J, Kropp T, Wiles R, Gray S, Campbell C: Body Burden: The Pollution in Newborns. Washington, DC: Environmental Working Group; 2005:83.
51. Hill AB: The environment and disease: Association or causation? Proc R Soc Med 1965, 58:295-300.
52. Coggon DI, Martyn CN: Time and chance: The stochastic nature of disease causation. Lancet 2005, 365:1434-1437.
53. NRC NRC: Review of the Environmental Protection Agency's State-of-The-Science Evaluation of Nonmonotonic Dose-response Relationships as they Apply to Endocrine Disruptors. Washington, DC: National Research Council of the National Academies; 2014.
54. Rooney AA, Boyles AL, Wolfe MS, Bucher JR, Thayer KA: Systematic review and evidence integration for literature-based environmental health science assessments. Environ Health Perspect 2014. Epub ahead of print.
55. Krauth D, Woodruff TJ, Bero L: Instruments for assessing risk of bias and other methodological criteria of published animal studies: A systematic review. Environ Health Perspect 2013, 121:985-992.
56. Beronius A, Molander L, Ruden C, Hanberg A: Facilitating the use of non-standard in vivo studies in health risk assessment of chemicals: A proposal to improve evaluation criteria and reporting. J Appl Toxicol 2014, 34:607-617.
57. Woodruff TJ, Sutton P: An evidence-based medicine methodology to bridge the gap between clinical and environmental health sciences. Health Aff (Millwood) 2011, 30:(5)931-7.
58. Klimisch HJ, Andreae M, Tillmann U: A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. Regul Toxicol Pharmacol 1997, 25:1-5.